Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Susan Spratt

Diabetes · Duke

View

Dr. Farah Khan

Diabetes · UWMC

View

Dr. Michael Shanik

Diabetes · SBU

View

Dr. Sarah Kim

Diabetes · UCSF

View

Dr. Austin Baraki

Obesity Medicine · Vineyard Health

View

Dr. Maria Fleseriu

Neuroendocrinology · OHSU Hospital

View

Dr. Priya Jaisinghani

Obesity Medicine · NYU Langone

View

Dr. John Stafford

General Endocrinology · OSUMC

View

Dr. David Cohen

Thyroid · RU

View

Dr. James Findling

Adrenal Diseases · Froedtert

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    SMDr. Sunder Mudaliar

    Dr. Sunder Mudaliar

    Endocrinology · Diabetes
    Jennifer Moreno Department of Veterans Affairs Medical Center
    sunder

    Research

    Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial

    2025

    Via Diabetes Care

    Research

    Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks

    2025

    Via Diabetes Care

    Research

    Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study

    2025

    Via Diabetes Care

    Research

    Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort

    2025

    Via Diabetes Care

    Research

    Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans

    2024

    Via Journal of Alzheimer's Disease

    Feb 12, 2024Journal Article

    Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study).

    ​

    Written by 1 Roon author & 14 others

    Via The American Heart Association Journals

    Research

    The Evolution of Diabetes Treatment Through the Ages: From Starvation Diets to Insulin, Incretins, SGLT2-Inhibitors and Beyond

    2023

    Via Journal of the Indian Institute of Science

    Research

    Astaxanthin, a Natural Antioxidant, Lowers Cholesterol and Markers of Cardiovascular Risk in Individuals with Prediabetes and Dyslipidaemia

    2023

    Via Diabetes, Obesity & Metabolism

    Research

    Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial

    2023

    Via JAMA Internal Medicine

    Research

    Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium-Glucose Cotransporter 2 Inhibitors

    2023

    Via Advances in Therapy

    Research

    Sodium-Glucose Co-Transporter-2 Inhibitors in Patients with Type 2 Diabetes: Barriers and Solutions for Improving Uptake in Routine Clinical Practice

    2022

    Via Diabetes, Obesity & Metabolism

    Research

    Increase in Hematocrit with SGLT-2 Inhibitors — Hemoconcentration from Diuresis or Increased Erythropoiesis after Amelioration of Hypoxia?

    2022

    Via Diabetes & Metabolic Syndrome

    Research

    SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy — A Novel Hypothesis

    2021

    Via The Journal of Clinical Endocrinology & Metabolism

    Research

    A Novel Hypothesis Linking Low-Grade Ketonaemia to Cardio-Renal Benefits with Sodium-Glucose Cotransporter-2 Inhibitors

    2021

    Via Diabetes, Obesity & Metabolism

    Research

    Changing the Diabetes Treatment Paradigm from Glucose Control to Cardiorenal Protection

    2021

    Via The Indian Journal of Medical Research